Miromatrix Medical Inc.
MIRONASDAQHealthcare
$3.39
+$0.02(+0.59%)
Market Cap$92951088
P/E Ratio—
52W High$4.35
52W Low$0.906
Miromatrix Medical Inc.（MIRO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MIRO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.95M | $0.03M | $0.05M | $0.25M |
| Cost of Revenue | $0.50M | $0.50M | $0.50M | $0.25M |
| Gross Profit | $0.45M | ($0.47M) | ($0.45M) | $0.00M |
| Gross Margin %(computed) | 47.56% | — | -974.58% | 0.00% |
| Operating Expenses | ||||
| R&D Expenses | $18.30M | $10.75M | $7.28M | $6.27M |
| G&A Expenses | $8.72M | $4.64M | $2.11M | $2.44M |
| Total Operating Expenses | $30.70M | $16.10M | $8.81M | $8.56M |
| Operating Income | ($30.25M) | ($16.96M) | ($10.26M) | ($8.99M) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.33M | $0.00M | $0.01M | $0.11M |
| Interest Expense | $0.05M | $0.68M | $0.77M | $0.05M |
| Income Before Tax | ($29.96M) | ($14.67M) | ($10.31M) | ($9.53M) |
| Income Tax Expense | $0.05M | $0.28M | ($1.59M) | ($6.46M) |
| Net Income | ($30.01M) | ($14.96M) | ($8.72M) | ($3.07M) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-1.45 | $-0.73 | $-0.82 | $-0.29 |
| Wtd Avg Shares | 20.73M | 20.40M | 10.57M | 10.48M |
| EBITDA | ($29.70M) | ($13.83M) | ($11.45M) | ($9.13M) |
| EBITDA Margin %(computed) | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Miromatrix Medical Inc.
关于Miromatrix Medical Inc.（MIRO）损益表
Miromatrix Medical Inc.（MIRO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，MIRO实现营收$0.00B，毛利润$0.00B（毛利率47.56%），净利润($0.03B)（净利率-3147.22%）。
常见问题
MIRO · 4 问Miromatrix Medical Inc.（MIRO）2022财年营收为$0.00B，同比up2783.5%。
MIRO revenueMIRO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09